UBS Group Has Lowered Expectations for Select Medical (NYSE:SEM) Stock Price

Select Medical (NYSE:SEM) had its price objective cut by investment analysts at UBS Group from $40.00 to $21.00 in a research note issued on Friday,Benzinga reports. The firm presently has a “neutral” rating on the health services provider’s stock. UBS Group’s price target points to a potential upside of 14.13% from the stock’s previous close.

Other equities analysts have also issued research reports about the company. Royal Bank of Canada boosted their target price on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. StockNews.com lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, December 30th. Finally, Benchmark lowered Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $39.50.

Select Medical Price Performance

Shares of SEM opened at $18.40 on Friday. The firm’s 50-day simple moving average is $26.91 and its two-hundred day simple moving average is $32.21. Select Medical has a fifty-two week low of $18.02 and a fifty-two week high of $40.98. The stock has a market cap of $2.38 billion, a PE ratio of 8.60, a price-to-earnings-growth ratio of 0.39 and a beta of 1.43. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. During the same quarter in the previous year, the business earned $0.46 earnings per share. The firm’s quarterly revenue was up 5.7% compared to the same quarter last year. Analysts anticipate that Select Medical will post 1.97 earnings per share for the current fiscal year.

Insider Activity at Select Medical

In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the transaction, the director now owns 22,000 shares of the company’s stock, valued at $463,980. The trade was a 59.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the sale, the vice president now directly owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. This trade represents a 14.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 19.14% of the stock is owned by company insiders.

Institutional Trading of Select Medical

Several institutional investors and hedge funds have recently added to or reduced their stakes in SEM. JPMorgan Chase & Co. raised its position in shares of Select Medical by 9.7% during the third quarter. JPMorgan Chase & Co. now owns 416,299 shares of the health services provider’s stock valued at $14,516,000 after buying an additional 36,905 shares during the last quarter. Principal Financial Group Inc. lifted its position in shares of Select Medical by 6.7% in the third quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock worth $82,208,000 after buying an additional 147,032 shares in the last quarter. Franklin Resources Inc. grew its holdings in Select Medical by 12.0% during the 3rd quarter. Franklin Resources Inc. now owns 69,448 shares of the health services provider’s stock valued at $2,354,000 after buying an additional 7,441 shares in the last quarter. Tidal Investments LLC purchased a new stake in shares of Select Medical during the 3rd quarter worth approximately $286,000. Finally, Wilmington Savings Fund Society FSB bought a new position in shares of Select Medical during the 3rd quarter valued at approximately $81,000. Institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.